Picture of Inhibikase Therapeutics logo

IKT Inhibikase Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Inhibikase Therapeutics Intends To Vigorously Dispute Pivot's Claims And Assert Counterclaims Against Pivot

April 30 (Reuters) - Inhibikase Therapeutics Inc
 IKT.O :
    * INHIBIKASE THERAPEUTICS INC - ON APRIL 26 RECEIVED NOTICE
OF
DEMAND FOR ARBITRATION WITH AMERICAN ARBITRATION ASSOCIATION
FROM PIVOT HOLDING LLC
    * INHIBIKASE-PIVOT ALLEGES BREACH OF CONTRACT BY CO FOR
FAILURE TO
PAY MILESTONE PAYMENTS,SEEKS DAMAGES OF $1.625 MILLION IN
MILESTONE PAYMENTS PLUS INTEREST
    * INHIBIKASE - BELIEVES THAT PIVOT'S CLAIMS ARE WITHOUT
MERIT AND
THAT COMPANY HASN'T OWED AND DOESN'T OWE ANY MILESTONE PAYMENTS
TO PIVOT
    * INHIBIKASE THERAPEUTICS INC - INTENDS TO VIGOROUSLY
DISPUTE
PIVOT'S CLAIMS AND ASSERT COUNTERCLAIMS AGAINST PIVOT

Source text for Eikon:  ID:n0001193125-24-123758 
Further company coverage:  IKT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Inhibikase Therapeutics

See all news